These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
172 related items for PubMed ID: 7651974
1. Synthesis and investigation of N4-substituted cytarabine derivatives as prodrugs. Fadl TA, Hasegawa T, Youssef AF, Farag HH, Omar FA, Kawaguchi T. Pharmazie; 1995 Jun; 50(6):382-7. PubMed ID: 7651974 [Abstract] [Full Text] [Related]
2. Lipophilic 5'-(alkyl phosphate) esters of 1-beta-D-arabinofuranosylcytosine and its N4-acyl and 2,2'-anhydro-3'-O-acyl derivatives as potential prodrugs. Rosowsky A, Kim SH, Ross J, Wick MM. J Med Chem; 1982 Feb; 25(2):171-8. PubMed ID: 7057424 [Abstract] [Full Text] [Related]
3. Synthesis of a lipid/peptide/drug conjugate: N4-(acylpeptidyl)-ara-C. Menger FM, Guo Y, Lee AS. Bioconjug Chem; 1994 Feb; 5(2):162-6. PubMed ID: 8031880 [Abstract] [Full Text] [Related]
4. Pharmacokinetic characteristics of L-valyl-ara-C and its implication on the oral delivery of ara-C. Cheon EP, Han HK. Acta Pharmacol Sin; 2007 Feb; 28(2):268-72. PubMed ID: 17241530 [Abstract] [Full Text] [Related]
5. Morpholinoalkyl ester prodrugs of diclofenac: synthesis, in vitro and in vivo evaluation. Tammara VK, Narurkar MM, Crider AM, Khan MA. J Pharm Sci; 1994 May; 83(5):644-8. PubMed ID: 8071813 [Abstract] [Full Text] [Related]
6. Synthesis, chemical and enzymatic hydrolysis, and bioavailability evaluation in rabbits of metronidazole amino acid ester prodrugs with enhanced water solubility. Mahfouz NM, Hassan MA. J Pharm Pharmacol; 2001 Jun; 53(6):841-8. PubMed ID: 11428660 [Abstract] [Full Text] [Related]
7. Prodrugs of peptides. 18. Synthesis and evaluation of various esters of desmopressin (dDAVP). Kahns AH, Buur A, Bundgaard H. Pharm Res; 1993 Jan; 10(1):68-74. PubMed ID: 8430062 [Abstract] [Full Text] [Related]
8. Enhanced cellular uptake of Ara-C via a peptidomimetic prodrug, L-valyl-ara-C in Caco-2 cells. Cheon EP, Hong JH, Han HK. J Pharm Pharmacol; 2006 Jul; 58(7):927-32. PubMed ID: 16805952 [Abstract] [Full Text] [Related]
9. Synthesis, transport and pharmacokinetics of 5'-amino acid ester prodrugs of 1-beta-D-arabinofuranosylcytosine. Sun Y, Sun J, Shi S, Jing Y, Yin S, Chen Y, Li G, Xu Y, He Z. Mol Pharm; 2009 Jul; 6(1):315-25. PubMed ID: 19115956 [Abstract] [Full Text] [Related]
10. N4-(dialkylamino)methylene derivatives of 2'-deoxycytidine and arabinocytidine: physicochemical studies for potential prodrug applications. Kerr SG, Kalman TI. J Pharm Sci; 1994 Apr; 83(4):582-6. PubMed ID: 8046619 [Abstract] [Full Text] [Related]
11. Cyclic amide derivatives as potential prodrugs II: N-hydroxymethylsuccinimide- / isatin esters of some NSAIDs as prodrugs with an improved therapeutic index. Mahfouz NM, Omar FA, Aboul-Fadl T. Eur J Med Chem; 1999 Apr; 34(7-8):551-62. PubMed ID: 11278041 [Abstract] [Full Text] [Related]
12. Evaluation of the conjugate between N4-(4-carboxybutyryl)-1-beta-D-arabinofuranosylcytosine and chitosan as a macromolecular prodrug of 1-beta-D-arabinofuranosylcytosine. Ichikawa H, Onishi H, Takahata T, Machida Y, Nagai T. Drug Des Discov; 1993 Apr; 10(4):343-53. PubMed ID: 8148473 [Abstract] [Full Text] [Related]
13. Bisphosphonate prodrugs: synthesis and in vitro evaluation of novel acyloxyalkyl esters of clodronic acid. Niemi R, Vepsäläinen J, Taipale H and, Järvinen T. J Med Chem; 1999 Dec 02; 42(24):5053-8. PubMed ID: 10585214 [Abstract] [Full Text] [Related]
14. Dimeric L-dopa derivatives as potential prodrugs. Di Stefano A, Mosciatti B, Cingolani GM, Giorgioni G, Ricciutelli M, Cacciatore I, Sozio P, Claudi F. Bioorg Med Chem Lett; 2001 Apr 23; 11(8):1085-8. PubMed ID: 11327596 [Abstract] [Full Text] [Related]
15. Synthesis and functional evaluation of a peptide derivative of 1-beta-D-arabinofuranosylcytosine. Balajthy Z, Aradi J, Kiss IT, Elödi P. J Med Chem; 1992 Sep 04; 35(18):3344-9. PubMed ID: 1527783 [Abstract] [Full Text] [Related]
16. Stability studies of some glycolamide ester prodrugs of niflumic acid in aqueous buffers and human plasma by HPLC with UV detection. Talath S, Shirote PJ, Lough WJ, Gadad AK. Arzneimittelforschung; 2006 Sep 04; 56(9):631-9. PubMed ID: 17063638 [Abstract] [Full Text] [Related]
17. Preparation, properties, reactions, and adenosine receptor affinities of sulfophenylxanthine nitrophenyl esters: toward the development of sulfonic acid prodrugs with peroral bioavailability. Yan L, Müller CE. J Med Chem; 2004 Feb 12; 47(4):1031-43. PubMed ID: 14761205 [Abstract] [Full Text] [Related]
18. Design, synthesis, and biological evaluation of aromatic ester prodrugs of 1-(3'-hydroxypropyl)-2-methyl-3-hydroxypyridin-4-one (CP41) as orally active iron chelators. Liu ZD, Liu DY, Lu SL, Hider RC. Arzneimittelforschung; 2000 May 12; 50(5):461-70. PubMed ID: 10858874 [Abstract] [Full Text] [Related]
19. Synthesis and evaluation of macromolecule-bound derivatives of a peptidyl-1-beta-D-arabinofuranosylcytosine prodrug. Balajthy Z. Drug Metab Lett; 2008 Apr 12; 2(2):83-9. PubMed ID: 19356076 [Abstract] [Full Text] [Related]
20. Antitumor characteristics of the conjugate of N4-(4-carboxybutyryl)-ara-C with ethylenediamine-introduced dextran and its resistance to cytidine deaminase. Onishi H, Pithayanukul P, Nagai T. Drug Des Deliv; 1990 Oct 12; 6(4):273-80. PubMed ID: 1707277 [Abstract] [Full Text] [Related] Page: [Next] [New Search]